Spectrum of Cervical Cytological Lesions in Premenopausal and Postmenopausal Women

  • Vaishali Baburao Nagose Department of Pathology, Mamata Medical College, Rotary Nagar, Khammam-507002. Telangana
  • Nirvana Rasaily Halder Department of Pathology, Mamata Medical College, Rotary Nagar, Khammam-507002. Telangana
  • Shruthi Amit Deshpande Department of Pathology, Mamata Medical College, Rotary Nagar, Khammam-507002. Telangana
  • Shivanand Shriram Rathod Department of Pathology, Mamata Medical College, Rotary Nagar, Khammam-507002. Telangana
  • Varsha Ashok Jadhav Department of Pathology, Mamata Medical College, Rotary Nagar, Khammam-507002. Telangana
Keywords: Pap smear, Premenopausal, Postmenopausal, ASCUS, HSIL, SCC

Abstract

Background:Screening with Pap smear initially targets women with higher prevalence of high grade precancerous cervical lesions [Cervical Intraepithelial Neoplasia 2/3 (CIN2/CIN3)] - women mostly in their third and fourth decade. But different conditions affect uterine cervix, including non neoplastic & neoplastic diseases, at different age. Thus, the Pap smears findings should vary in premenopausal & post menopausal groups.Methods: A prospective study of two years was conducted to screen Pap smears in women who were categorised as premenopausal age group <46 years & postmenopausal ≥46years.Result: A total of 6647 cases were analysed within age ranging from 18 to 85 years. 5369 (80.77%) patients were in premenopausal & 1278 (19.23%) in postmenopausal age group. Premenopausal group showed interpretation as “Negative for Intraepithelial Lesion or Malignancy” (NILM) in 97.56%. Here, two of the three cases of Squamous Cell Carcinoma (SCC) were of < 40 years. Postmenopausal age group showed maximum cases of Atypical Squamous Cells of Undetermined Significance (ASCUS), Low Grade Squamous Intraepithelial Lesion (LSIL) & SCC. Maximum cases of High-Grade Squamous Intraepithelial Lesion (HSIL) belonged to >60 years.Conclusion: It is suggested that the Pap screening should not be ceased, but be continued beyond 60 years of age. In premenopausal age, along with SIL, the possibility of malignancy should not be neglected & infections should also be paid more attention. Thus, irrespective of the age of female after 30 yrs, it is highly recommended for them to undergo PAP screening. DOI: 10.21276/APALM.1661

Author Biography

Vaishali Baburao Nagose, Department of Pathology, Mamata Medical College, Rotary Nagar, Khammam-507002. Telangana
Assistant Professor, Department of Pathology, Mamata Medical College, Khammam, Telangana, India.

References

1.Poste P, Patil A, Andola S. Incidence of Non-Neoplastic Cervical Pathologies Recorded at a Medical College. IJRRAS. 2015; 2(2): 039-050.

2.Lowe D G Caricnoma of the cervix with massive eosinophilia. BJOG.1988; 95: 393-401.

3.Paavonen J et al. Etiology of cervical inflammation. Am J Obstet Gynecol. 1986; 154(3): 556-64.

4.Kerkar RA, Kulkarni YV. Screening for cervical cancer: An overview. J Obstet Gynecol India. 2006; 56: 115‑22.

5.Wahi PN, Luthar UK, Mali S, Shimkin MB. Prevalence and distribution of cancer of the uterine cervix in Agra district, India. Cancer. 1972; 30: 720-725.

6.Abell M.R., Ramirez J.A. Sarcomas and carcinosarcomas of the uterine cervix. Cancer. 1973; 31: 1176- 1192.

7.Afrakhteh M, Khodakarami N, Moradi A, Alavi E, Shirazi FH. A study of 13315 papanicolaou smear diagnoses in Sohada hospital. J Fam Reprod Health. 2007; 1: 75‑9.

8.Ahuja M. Age of menopause and determinants of menopause age: A PAN India survey by IMS. J Midlife Health. 2016; 7(3): 126–131.

9.ICMR. Consensus document of the management of cancer cervix.Prepared as an outcome of ICMR subcommittee on cervix cancer. 2016

10.Deepthi KN, Aravinda Macharla. Lesions of uterine cervix by cytologyand histopathology- A prospective study for a period of two years. Indian Journal of Pathology and Oncology. 2017; 4(2): 193-198.

11. Shashidhar MR, Shikha Jayasheelan. Prevalence of cervical cancer and role of screening programmes by PAP smears. MedPulse International Journal of Pathology, 2017; 1(2): 32-36.

12. Pushpalatha K, Pramila GR, Sudhakar R. Comparative study of visual inspection with acetic acid (VIA), Pap smear and biopsy for cervical cytology. Indian Journal of Pathology and Oncology. 2017; 4(2): 232-236.

13. Sharadamani GS, Anusha N. Spectrum of Cervical Lesions Detected by Pap Smear: An Experience from a Rural-Based Tertiary Care Teaching Hospital. Indian Journal of Pathology: Research and Practice. 2017; 6 (2)(2): 435-438.

14. Ali SS, Prabhu MH, Deoghare S, InamdarSS, Deepak N. Spectrum ofCervical Lesions by Papanicolaou (Pap) Smear Screening in Remote Area of Bagalkot- A Camp Approach. Int. J. Life. Sci. Scienti. Res. 2017; 3(3): 986-991.

15. Sujatha R, Archana, Saravanakumar N, Subramaniam PM. Study of cervical PAP smear at medical college hospital in a rural setup. Indian Journal of Obstetrics and Gynecology Research 2017; 4(2):189-192.

16.Umarani MK, Gayathri MN, MadhuKumar R. Study of cervical cytology in Papanicolaou (Pap) smears in a tertiary care hospital. Indian Journal of Pathology and Oncology, October-December 2016; 3(4); 679-683.

17. Sujatha P, Indira V, Kandukuri MK. Study of PAP smear examination in patients complaining of leucorrhoea - A 2 years prospective study in a teaching hospital. IAIM. 2016; 3(5): 106-112.

18. Geethu GN, Shamsuddin F, Narayanan T, Balan P. Cytopathological pattern of cervical pap smears - a study among population of North Malabar in Kerala. Indian Journal of Pathology and Oncology. 2016; 3(4); 552-557.

19. Chaithanya K, Kanabur DR, Parshwanath HA. Cytohistopathological Study of Cervical Lesions. International Journal of Scientific Study. 2016; 4(2): 137-140.

20.Atla BL, Uma P, Shamili M., SatishKumar S. Cytological patterns of cervical pap smears with histopathological correlation. Int J Res Med Sci. 2015; 3(8): 1911-1916.

21.Roberts TH, Ng AB. Chronic lymphocytic cervicitis: cytologic and histopathologic manifestations. Acta Cytol. 1975; 19(3): 235-43.

22.R G Blanks, S M Moss, S Addou, D A Coleman, and A J Swerdlow. Risk of cervical abnormality after age 50 in women with previously negative smears. Br J Cancer. 2009; 100(11): 1832–1836.

23.World – both sexes estimated incidence by age. [Accessed October 30, 2014]. Available from:http://www.globocan.iarc.fr/old/age_specific_table_r.asp?

24.Olga BI & Michael RH. (2015) Ch 36 The Uterine Cervix. In Silverberg’s Principles & Practice of Surgical Pathology & Cytopathology. 5th Edition. (pp. 2537-2592) Cambridge University Press.
Published
2017-12-22
Section
Original Article